ScholarWorks@Sookmyung Women's University: Bang, Joon Seok

Detailed Information

Bang, Joon Seok (방준석)

약학대학 (약학부)

Research Area: 임상약학, 임상약리학, 노인약학, 약물치료학, Clinical Pharmacy, Clinical Pharmacology, Geriatric Pharmacy, Pharmacotherapeutics

Tel 02-2077-7526
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Oxidative stress:3||national health insurance:2||pegfilgrastim:2||Alzheimer's disease:2||Osteoporosis:2||budget impact:2||public health:2||AMPK:2||rare disease:2||pharmacist:2||3hydroxymorphinan:2||Autophagy:2||Inflammation:2||Adipocytes:1||Akt:1||Alendronate:1||Apoptosis:1||Astrocyte:1||Baicalin:1||Benzyl isothiocyanate:1||Bioavailability:1||Bisphosphonate:1||Bone Mineral Density:1||Browning:1||CDC:1||CPI17:1||CYP2C9:1||CYP3A4:1||Calcium influx:1||Capmatinib:1||Characteristics of digital therapeutics:1||Colistimethate:1||Community pharmacy:1||Complication:1||Convergence:1||DLBCL:1||Deoxycholic acid:1||Diabetes:1||Dog plasma:1||Drugs:1||ER stress:1||ERK:1||Edema:1||Elderly patient:1||Endoplasmic reticulum stress:1||Endothelium:1||Evening primrose seeds:1||Fluoride:1||Fluvastatin:1||Fracture Risk:1||Galangin:1||Glutamate:1||Gramnegative bacteria:1||Growth plate:1||HMGCoA Reductase Inhibitor:1||Hepatocyte:1||Highperformance liquid chromatography:1||Humulus japonicus:1||Hypoxia:1||IC87114:1||Infant's drugs:1||Insulin resistance:1||Insulinlike growth factor:1||Irritable Bowel Syndrome:1||Isosalipurposide:1||Korea:1||Larginine:1||Labelling trend:1||Lipogenesis:1||Lysosomal dysfunction:1||MERS:1||MITF:1||MYPT1:1||Macrolactin A:1||Management education:1||Melanocytes:1||Microglial activation:1||Mitochondria:1||Myocyte:1||NAFLD:1||NO synthase:1||NSAIDs:1||Nitric oxide:1||Nonalcoholic fatty liver disease:1||North Korea:1||North Korean defecting women:1||Nrf2:1||ORP150:1||OTC:1||Obesity:1||Orphan drug:1||Orphan drugs:1||Osteopenia:1||Oxaliplatin:1||Pcoumaric acid:1||Pglycoprotein:1||PMN infiltration:1||PPARδ:1||PXR:1||Peripheral neuropathy:1||Pharmaceutical company:1||Pharmacist:1||Phbsphatidylcholine:1||Phloretin:1||Phorbol ester:1||Phosphatidylcholine (PC):1||Phragmites rhizome:1||Postmenopausal Women:1||Proliferation:1||R&D investment:1||RCHOP:1||RCHOP regimen:1||RIFLE criteria:1||ROCK:1||ROCK(Rhoassocidated:1||ROCK(Rho연관 인산화효소):1||ROME IV:1||Raloxifene:1||Repaglinide:1||Retinopathy:1||Risk sharing agreement:1||SERM:1||Side effects:1||Statin:1||Tar color additives:1||Tibial length:1||Tyrosinase:1||UV detection:1||User evaluations:1||Vasoconstriction:1||Zika virus:1||acetylcholine:1||adefovir:1||adhesion control standards:1||adverse reactions:1||agingsociety:1||antifatigue:1||antistress:1||antitumor efficacy:1||artificial intelligence:1||awareness of contraception:1||bile acids:1||binge eating disorder:1||biodistribution:1||biological monitoring:1||brain:1||bronchoalveolar lavage fluid:1||budget controls:1||bulimia nervosa:1||cancer:1||cause:1||chenodeoxycholic acid:1||child:1||cholic acid:1||cholinergic system:1||claims data:1||clinical training:1||cognitive function:1||coiledcoil containing protein kinase):1||company performance:1||compartmental:1||contact time:1||correlation:1||deoxycholic acid:1||disease predictor map:1||dispensing:1||donepezil:1||drug abuse:1||drug use:1||efficacy:1||entrusted pharmacist:1||epigenetic changes:1||extremely low frequency magnetic field (ELFMF):1||febrile neutropenia:1||female college students:1||filgrastim:1||galantamine:1||gastric cancer:1||genetic polymorphism:1||geriatric pharmacy specialist:1||granulocyte colony stimulating factor:1||health services accessibility:1||hospital pharmacist:1||hydrophilic polymer:1||hyperalgesia:1||immunization:1||immunohistochemistry:1||insurance finance:1||internet:1||lamivudine:1||longterm care:1||mPEGPDLLA:1||malabsorption:1||manganese (Mn), exposure:1||marketing expense:1||memantine:1||micellar paclitaxel:1||modified FOLFOX6:1||molecular weight:1||mucoadhesion:1||multidrugresistance:1||neutropenia:1||nitric oxide:1||nitric oxide synthase:1||nonhodgikin's lymphoma:1||nonprescription drug:1||nursing home:1||online pharmacy:1||operating profit:1||oral contraceptives:1||oxaliplatin:1||oxidative damage:1||p38:1||paclitaxel (Taxol (R)):1||pain relieving patch:1||parents:1||patient access:1||patient accessibility:1||pediatric:1||pentaogalloyl βDglucose:1||peripheral neuropathy:1||pharmaceutical care service:1||pharmaceutical expenditure:1||pharmaceutical pricing:1||pharmacokinetic:1||pharmacy education:1||polysacchariderich extract of Phragmites rhizoma (PEP):1||precepting:1||preceptor:1||price:1||pricing and reimbursement:1||primary defense:1||quality control:1||reimbursement:1||reunification:1||risk factor:1||risk sharing:1||rivastigmine:1||sales growth rate:1||selfmedication:1||side effects:1||singlenucleotide polymorphism:1||skin adverse effect:1||sodium nitroprusside:1||stress:1||surface area:1||susceptibility:1||theory of planned behavior:1||thickness:1||tinnitus:1||topiramate:1||transcription factor:1||treatment:1||uncertainty measurement:1||vaccine:1||warfarin:1||water immersion restraint (WIR)induced stress:1||women’s health:1||young children:1||내피:1||융합:1||플로레틴:1||<bold>Humulus japonicus</bold>:1||혈관수축:1||<bold>dyslipidemia</bold>:1||<bold>highfat diet</bold>:1||<bold>nonalcoholic fatty liver disease</bold>:1||<bold>obesity</bold>:1||7OSuccinyl macrolactin A:1||ACG guideline:1||AGS cell:1||AMPactivated protein kinase:1||ANC:1||Abietic acid:1||Acute kidney injury:1||Adherence:1||

STATISTICS: Total View :6,530,075; Today View :8,687

RSS_1.0 RSS_2.0 ATOM_1.0

Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE